EUVIMEDEUVIMED entdecken
Crossref

Discovery of 1,2,4-Triazole-3-thione Derivatives as Potent and Selective DCN1 Inhibitors for Pathological Cardiac Fibrosis and Remodeling

Zhang-Xu He, Ge Gao, Hui Qiao, Guan-Jun Dong iD, Zengyangzong Dan, Ya-Lan Li, Yu-Ruo Qi, Qian Zhang, Shuo Yuan, Hong-Min Liu, Jianzeng Dong, Wen Zhao iD und 1 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Zhang-Xu He und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China. Hauptthemen laut MEDLINE: Triazoles, Fibrosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DCN1, a critical co-E3 ligase during the neddylation process, is overactivated in many diseases, such as cancers, heart failure as well as fibrotic diseases, and has been regarded as a new target for drug development. Herein, we designed and synthesized a new class of 1,2,4-triazole-3-thione-based DCN1 inhibitors based the hit HD1 identified from high-throughput screening and optimized through numerous structure-activity-relationship (SAR) explorations. HD2 (IC50= 2.96 nM) was finally identified and represented a highly potent and selective DCN1 inhibitor with favorable PK properties and low toxicity. Amazingly, HD2 effectively relieved Ang II/TGFβ-induced cardiac fibroblast activation in vitro, and reduced ISO-induced cardiac fibrosis as well as remodeling in vivo, which was linked to the inhibition of cullin 3 neddylation and its substrate Nrf2 accumulation. Our findings unveil a novel 1,2,4-triazole-3-thione-based derivative HD2, which can be recognized as a promising lead compound targeting DCN1 for cardiac fibrosis and remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesFibrosisAnimalsStructure-Activity RelationshipHumansThionesMiceDrug DiscoveryMaleRatsRats, Sprague-DawleyMice, Inbred C57BLVentricular Remodeling

Substanzen

TriazolesThiones1,2,4-triazole

Autor:innen und Institutionen

  • Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China.
  • State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzho…
  • Henan Children's Hospital, Zhengzhou Children's Hospital, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
  • Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • China Meheco Topfond Pharmaceutical Co., Zhumadian 463000, China.
  • Key Laboratory of Cardiocerebrovascular Drugs, Zhumadian 463000, Henan Province, China.

ORCID-Profile: Guan-Jun Dong, Wen Zhao, Li-Ying Ma

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

He, Z. X., Gao, G., Qiao, H., Dong, G. J., Dan, Z., Li, Y. L., Qi, Y. R., Zhang, Q., Yuan, S., Liu, H. M., Dong, J., Zhao, W., & Ma, L. Y. (2024). Discovery of 1,2,4-Triazole-3-thione Derivatives as Potent and Selective DCN1 Inhibitors for Pathological Cardiac Fibrosis and Remodeling. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00713

Vancouver

He ZX, Gao G, Qiao H, Dong GJ, Dan Z, Li YL, et al. Discovery of 1,2,4-Triazole-3-thione Derivatives as Potent and Selective DCN1 Inhibitors for Pathological Cardiac Fibrosis and Remodeling. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00713

BibTeX
@article{He2024,
  author = {He, Zhang-Xu and Gao, Ge and Qiao, Hui and Dong, Guan-Jun and Dan, Zengyangzong and Li, Ya-Lan and Qi, Yu-Ruo and Zhang, Qian and Yuan, Shuo and Liu, Hong-Min and Dong, Jianzeng and Zhao, Wen and Ma, Li-Ying},
  title = {Discovery of 1,2,4-Triazole-3-thione Derivatives as Potent and Selective DCN1 Inhibitors for Pathological Cardiac Fibrosis and Remodeling},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00713}
}
Kostenlos starten →